FinancingRoche leads Freenome Inc US$257m financingLatest NewsMulti-omics liquid biospy specialist Freenome Inc. has baged US$254m in a financing round led by Roche AG to fund early cancer detection in 6,200 patients using its AI-guided cancer detection platform. Read more 16 February 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/Freenome.jpg 691 1920 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-02-16 09:14:352024-07-08 11:34:29Roche leads Freenome Inc US$257m financing